Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05854966
Title CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries


No variant requirements are available.